Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bluma Brenner

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Antimicrobial Agents and Chemotherapy|April 7, 2010
Predicting tipranavir and darunavir resistance using genotypic, phenotypic, and virtual phenotypic resistance patterns: an independent cohort analysis of clinical isolates highly resistant to all other protease inhibitorsAnnie Talbot, Philip Grant, Jonathan Taylor, et al.
AIDS (London, England)|August 12, 2011
Dates of HIV infection can be estimated for seroprevalent patients by coalescent analysis of serial next-generation sequencing dataArt F Y Poon, Rachel A McGovern, Theresa Mo, et al.
Antimicrobial Agents and Chemotherapy|October 4, 2006
High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimensFlorence Doualla-Bell, Ava Avalos, Bluma Brenner, et al.
Plos One|October 9, 2014
A significant reduction in the frequency of HIV-1 drug resistance in Québec from 2001 to 2011 is associated with a decrease in the monitored viral loadHugues Charest, Florence Doualla-Bell, Régis Cantin, et al.
The Journal of Antimicrobial Chemotherapy|January 11, 2017
Purification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitorsHong-Tao Xu, Said A Hassounah, Susan P Colby-Germinario, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2006
Impact of human immunodeficiency virus type 1 subtype C on drug resistance mutations in patients from Botswana failing a nelfinavir-containing regimenFlorence Doualla-Bell, Ava Avalos, Tendani Gaolathe, et al.
Open Forum Infectious Diseases|March 23, 2019
In-depth Sampling of High-risk Populations to Characterize HIV Transmission Epidemics Among Young MSM Using PrEP in France and QuebecAntoine Chaillon, Constance Delaugerre, Bluma Brenner, et al.
The Lancet. HIV|September 16, 2023
Checklist for studies of HIV drug resistance prevalence or incidence: rationale and recommended useLawrence Mbuagbaw, Cristian Garcia, Bluma Brenner, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Antimicrobial Agents and Chemotherapy|April 7, 2010
Predicting tipranavir and darunavir resistance using genotypic, phenotypic, and virtual phenotypic resistance patterns: an independent cohort analysis of clinical isolates highly resistant to all other protease inhibitorsAnnie Talbot, Philip Grant, Jonathan Taylor, et al.
AIDS (London, England)|August 12, 2011
Dates of HIV infection can be estimated for seroprevalent patients by coalescent analysis of serial next-generation sequencing dataArt F Y Poon, Rachel A McGovern, Theresa Mo, et al.
Antimicrobial Agents and Chemotherapy|October 4, 2006
High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimensFlorence Doualla-Bell, Ava Avalos, Bluma Brenner, et al.
Plos One|October 9, 2014
A significant reduction in the frequency of HIV-1 drug resistance in Québec from 2001 to 2011 is associated with a decrease in the monitored viral loadHugues Charest, Florence Doualla-Bell, Régis Cantin, et al.
The Journal of Antimicrobial Chemotherapy|January 11, 2017
Purification of Zika virus RNA-dependent RNA polymerase and its use to identify small-molecule Zika inhibitorsHong-Tao Xu, Said A Hassounah, Susan P Colby-Germinario, et al.
Antimicrobial Agents and Chemotherapy|May 26, 2006
Impact of human immunodeficiency virus type 1 subtype C on drug resistance mutations in patients from Botswana failing a nelfinavir-containing regimenFlorence Doualla-Bell, Ava Avalos, Tendani Gaolathe, et al.
Open Forum Infectious Diseases|March 23, 2019
In-depth Sampling of High-risk Populations to Characterize HIV Transmission Epidemics Among Young MSM Using PrEP in France and QuebecAntoine Chaillon, Constance Delaugerre, Bluma Brenner, et al.
The Lancet. HIV|September 16, 2023
Checklist for studies of HIV drug resistance prevalence or incidence: rationale and recommended useLawrence Mbuagbaw, Cristian Garcia, Bluma Brenner, et al.
Pageof 4